SEQUENTIAL USE OF FIB-4 AND NIS2+™ FOR AN ACCURATE DETECTION OF NONCIRRHOTIC AT-RISK NASH PATIENTS FOR ENROLLMENT IN NASH CLINICAL TRIALS

Category Primary study
ConferenceHepatology
Year 2023
This article has no abstract
Epistemonikos ID: dda76d5b13a2214839eb4991bc8d7d8996389a62
First added on: Apr 30, 2026